T1	Concept 5 18	mutation rate
A1	Emphasized T1
T2	Concept 20 47	human to human transmission
T3	Concept 49 62	survival time
T4	Concept 66 78	up to 4 days
T5	Concept 79 117	under various environmental conditions
T6	Concept 122 139	lack of treatment
T7	Action 140 145	makes
T8	Reference 146 148	it
T9	Concept 161 179	bioterrorism agent
T10	Concept 151 160	potential
R2	has-property Arg1:T3 Arg2:T4	
R3	has-property Arg1:T4 Arg2:T5	
R4	has-property Arg1:T4 Arg2:T6	
R5	subject Arg1:T7 Arg2:T3	
R6	is-a Arg1:T8 Arg2:T9	
R1	has-property Arg1:T8 Arg2:T10	
R7	subject Arg1:T7 Arg2:T2	
R8	subject Arg1:T7 Arg2:T1	
R9	target Arg1:T7 Arg2:T8	
T11	Concept 182 200	seasonality factor
T12	Concept 204 207	0.5
R10	has-property Arg1:T11 Arg2:T12	
T14	Concept 227 236	amplitude
T15	Concept 240 258	seasonal variation
T16	Concept 262 264	R0
T17	Concept 269 279	SARS-CoV-2
T20	Concept 309 327	seasonal variation
T21	Concept 331 333	R0
T22	Concept 348 365	betacoronaviruses
T23	Concept 342 347	other
R12	has-property Arg1:T22 Arg2:T23	
T24	Action 280 282	is
R13	has-property Arg1:T15 Arg2:T14	
R15	in-context Arg1:T15 Arg2:T16	
R16	has-property Arg1:T17 Arg2:T15	
R14	subject Arg1:T24 Arg2:T14	
R19	in-context Arg1:T20 Arg2:T21	
R20	has-property Arg1:T22 Arg2:T20	
T13	Concept 283 301	half the amplitude
R11	has-property Arg1:T20 Arg2:T13	
R17	target Arg1:T24 Arg2:T13	
R18	entails Arg1:T11 Arg2:T13	
T18	Concept 377 384	efforts
A2	Emphasized T18
T25	Action 422 432	to provide
T26	Concept 435 439	fast
T27	Concept 444 452	reliable
T28	Concept 453 470	diagnostic method
T29	Concept 475 485	SARS-CoV-2
T19	Concept 405 421	around the world
R21	in-context Arg1:T18 Arg2:T19	
R22	subject Arg1:T25 Arg2:T18	
R23	target Arg1:T25 Arg2:T28	
R24	has-property Arg1:T28 Arg2:T27	
R25	has-property Arg1:T28 Arg2:T26	
R26	in-context Arg1:T28 Arg2:T29	
T30	Concept 499 510	dN/dS ratio
T31	Concept 514 524	RBD region
T32	Concept 528 544	SARS-CoV-2 WIV04
T34	Concept 581 587	3 fold
A3	Uncertain T34
T35	Concept 607 624	full spike region
R29	in-place Arg1:T30 Arg2:T31	
T33	Action 562 571	increased
R27	target Arg1:T33 Arg2:T30	
R28	subject Arg1:T33 Arg2:T32	
R30	in-time Arg1:T30 Arg2:T34	
T36	Concept 588 601	in comparison
R31	in-context Arg1:T33 Arg2:T36	
R32	in-context Arg1:T36 Arg2:T35	
T38	Concept 728 732	DPP4
T39	Concept 667 679	MERS-CoV RBD
T40	Action 734 737	are
T41	Concept 755 763	SARS-CoV
T42	Concept 768 778	SARS-CoV-2
T43	Concept 642 663	critical key residues
T44	Concept 638 641	six
R33	has-property Arg1:T43 Arg2:T44	
R34	in-context Arg1:T43 Arg2:T39	
T45	Concept 691 703	its receptor
T37	Concept 704 726	dipeptidyl peptidase 4
*	same-as T37 T38
R35	has-property Arg1:T45 Arg2:T37	
R36	in-context Arg1:T43 Arg2:T45	
R37	subject Arg1:T40 Arg2:T43	
T46	Concept 742 751	different
A4	Emphasized T46
R38	target Arg1:T40 Arg2:T46	
R39	in-context Arg1:T46 Arg2:T41	
R40	in-context Arg1:T40 Arg2:T42	
